<DOC>
	<DOC>NCT02486874</DOC>
	<brief_summary>PoreSkin, a human acellular dermal matrix (hADM) manufactured by Faculty of Medicine, Chulalongkorn University, is the first human dermal substitute developed in Thailand. It is a permanent dermal substitute aiming to reduce skin contracture. The objective of this study is to assess the safety and ability in achieving durable and cosmetic coverage of PoreSkin.</brief_summary>
	<brief_title>Clinical Evaluation of PoreSkin</brief_title>
	<detailed_description />
	<criteria>Male and female patients 1860 years with burn scar contracture and hypertrophic scar Undergoing immunosuppressive therapy Immunocompromise host (DM, HIV infected) Evidence of malnutrition Active malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Human acellular dermal matrix, burns, wound healing</keyword>
</DOC>